HMG-CoA reductase is regulated by salinity at the level of transcription in Haloferax volcanii

被引:29
|
作者
Bidle, Kelly A.
Hanson, Thomas E.
Howell, Koko
Nannen, Jennifer
机构
[1] Rider Univ, Dept Biol, Lawrenceville, NJ 08648 USA
[2] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA
[3] Univ Delaware, Grad Coll Marine Studies, Newark, DE 19711 USA
基金
美国国家科学基金会;
关键词
haloarchaea; HMG-CoA reductase; salt regulation; lipids; carotenoids;
D O I
10.1007/s00792-006-0008-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The moderately halophilic archaeon Haloferax volcanii was surveyed for protein profile changes correlated with growth at high and low salinity. A single polypeptide with an approximate mass of 46 kDa was conspicuously more abundant during growth at high salinity. This protein was identified as HMG-CoA reductase (HMGR), encoded by the hmgR gene. HMGR is a key enzyme in the mevalonate pathway of isoprenoid biosynthesis, the sole route in haloarchaea for lipid and carotenoid production. Enzymatic assays confirmed that HMGR activity is more abundant in cells grown at high salinity. Low salt cultures of H. volcanii contained lower amounts of hmg R transcript compared to cells grown in high salt suggesting that the observed regulation occurs at the level of transcription. Paradoxically, both lipid and carotenold content decreased in H. volcanii grown at high salinity despite the increased levels of HMGR specific activity. To our knowledge, this is the first report demonstrating that the expression of HMGR is regulated in response to non-optimal salinity in a halophilic archaeon.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 50 条
  • [1] HMG-CoA reductase is regulated by salinity at the level of transcription in Haloferaxvolcanii
    Kelly A. Bidle
    Thomas E. Hanson
    Koko Howell
    Jennifer Nannen
    Extremophiles, 2007, 11 : 49 - 55
  • [2] SYNTHESES OF HMG-COA REDUCTASE INHIBITORS
    MIYACHI, N
    SUZUKI, M
    OHARA, Y
    HIYAMA, T
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1995, 53 (03) : 186 - 196
  • [3] HMG-CoA reductase inhibitors in atherosclerosis.
    Buckley, BM
    INSULIN RESISTANCE, METABOLIC DISEASES AND DIABETIC COMPLICATIONS, 1999, 1177 : 219 - 224
  • [4] Regulation of HMG-CoA reductase in mammals and yeast
    Burg, John S.
    Espenshade, Peter J.
    PROGRESS IN LIPID RESEARCH, 2011, 50 (04) : 403 - 410
  • [5] THE DISCOVERY AND DEVELOPMENT OF HMG-COA REDUCTASE INHIBITORS
    ENDO, A
    JOURNAL OF LIPID RESEARCH, 1992, 33 (11) : 1569 - 1582
  • [6] A QM/MM Evaluation of the Missing Step in the Reduction Mechanism of HMG-CoA by Human HMG-CoA Reductase
    Mihaljevic-Juric, Paula
    Sousa, Sergio F.
    PROCESSES, 2021, 9 (07)
  • [7] Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase
    Pak, Valeriy V.
    Kwon, Dae Yong
    Khojimatov, Olim K.
    Pak, Aleksandr, V
    Sagdullaev, Shomansur Sh
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (03) : 1923 - 1931
  • [8] Statins (HMG-CoA reductase inhibitors), cholesterol and stroke
    Marta-Moreno, J
    Echeandia, C
    Oliveros-Cid, A
    Figuerola, A
    Mola, S
    REVISTA DE NEUROLOGIA, 1998, 27 (159) : 827 - 830
  • [9] Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase
    Valeriy V. Pak
    Dae Yong Kwon
    Olim K. Khojimatov
    Aleksandr V. Pak
    Shomansur Sh. Sagdullaev
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 1923 - 1931
  • [10] Lipid-Producing Ciliochoroidal Melanoma with Expression of HMG-CoA Reductase
    Van Ly, David
    Wang, Duo
    Conway, Robert Max
    Giblin, Michael
    Liang, Sharron
    Lukeis, Robyn
    Lim, Li-Anne
    Hesson, Luke
    Cherepanoff, Svetlana
    OCULAR ONCOLOGY AND PATHOLOGY, 2020, 6 (06) : 416 - 421